Breaking News, Collaborations & Alliances

Polyphor, Boehringer Form Discovery Pact

MacroFinder technology to identify and optimize macrocyclic drug candidates

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Polyphor Ltd. and Boehringer Ingelheim have signed a research collaboration and license agreement, under which Polyphor will apply its MacroFinder drug discovery technology to identify and optimize macrocyclic drug candidates against targets selected by Boehringer. Polyphor will receive an up-front payment, research funding, and development milestones, and is eligible to receive royalties on sales.   Polyphor will apply the MacroFinder Technology to identify novel drug candidates and to optimize...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters